샘플 요청 목록

 카트 문의
시장보고서
상품코드
1760835

세계의 조직진단 시장

Tissue Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 552 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

조직진단 세계 시장은 2030년까지 95억 달러에 이를 전망

2024년에 65억 달러로 추정되는 조직진단 세계 시장은 2024-2030년간 CAGR 6.6%로 성장하여 2030년에는 95억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 소모품은 CAGR 6.8%를 나타내고, 분석 기간 종료시에는 84억 달러에 이를 것으로 예측됩니다. 기기 부문의 성장률은 분석 기간중 CAGR 5.2%로 추정됩니다.

미국 시장은 22억 달러로 추정, 중국은 CAGR 9.2%로 성장 예측

미국의 조직진단 시장은 2024년에 22억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 10억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 9.2%로 예상됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 4.9%와 6.2%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 5.6%를 보일 전망입니다.

세계의 조직진단 시장 - 주요 동향과 촉진요인 정리

조직진단과 그 중요성은?

조직진단은 질병, 특히 암을 진단하기 위해 조직 샘플을 분석하는 것을 포함합니다. 이 분야에는 병리조직학, 면역조직화학, in situ hybridization, 디지털 병리학 등의 기술이 포함됩니다. 조직진단은 정확한 질병 진단, 예후, 치료 계획을 세우는데 매우 중요합니다. 세포 구조의 검사, 비정상 세포의 식별, 다양한 질병과 관련된 특정 바이오마커의 검출이 가능합니다. 조직진단의 정확성과 신뢰성은 임상적 판단의 지침이 되고 환자의 예후를 개선하는 데 필수적입니다.

기술의 발전은 이 시장을 어떻게 형성하고 있는가?

기술의 발전이 조직진단 시장을 크게 형성하고 있습니다. 조직 샘플을 디지털화하여 분석 및 저장하는 디지털 병리학의 개발은 이 분야에 혁명을 불러일으키고 있습니다. 디지털 병리학은 원격 진료를 가능하게 하고, 진단의 정확도를 높이며, 연구와 교육을 위한 데이터 공유를 용이하게 합니다. 고해상도 스캐너 및 AI 기반 이미지 분석과 같은 영상 기술의 발전은 조직 이상 발견 및 특성화를 향상시키고 있습니다. 또한, 분자진단과 조직 분석의 통합은 질병의 유전적, 분자적 기반에 대한 깊은 통찰력을 제공하여 보다 맞춤화된 표적 치료로 이어지고 있습니다.

이 산업에서 시장 수요는 어떤 역할을 하는가?

시장 수요가 조직진단 시장에 큰 변화를 가져오고 있습니다. 암 및 기타 만성 질환의 유병률 증가로 인해 정확하고 시기적절한 진단에 대한 필요성이 높아지면서 고급 조직 진단 도구에 대한 수요가 증가하고 있습니다. 상세한 분자 및 유전자 분석이 필요한 개인 맞춤형 의료로의 전환은 혁신적인 조직 진단 기술의 개발 및 채택에 영향을 미치고 있습니다. 다양한 질병에 걸릴 확률이 높은 노인 인구 증가는 첨단 진단 기기에 대한 수요를 더욱 증가시키고 있습니다. 또한, 질병의 조기 발견과 예방 의료에 대한 관심이 높아짐에 따라 검사 기관과 의료 기관은 최첨단 조직 진단 솔루션에 대한 투자를 늘리고 있습니다.

시장 성장을 가속하는 요인은 무엇인가?

조직진단 시장의 성장은 암 및 기타 만성질환의 발병률 증가, 진단 기술의 발전, 의료비 지출 증가 등 여러 요인에 의해 주도되고 있습니다. 조기 발견은 치료 결과를 크게 향상시키기 때문에 정밀하고 빠른 진단 도구에 대한 수요가 시장 성장을 주도하고 있습니다. 디지털 병리학 및 AI 기반 진단 도구와 같은 기술 혁신은 질병 진단의 효율성과 정확성을 높이고 있습니다. 또한, 개인 맞춤형 의료에 대한 관심이 높아지면서 상세한 분자 및 유전학적 통찰력을 제공할 수 있는 첨단 조직 진단에 대한 필요성이 증가하고 있습니다. 또한, 신흥 시장의 의료 인프라 확대와 진단 능력을 향상시키기 위한 정부의 이니셔티브도 시장 성장에 기여하고 있습니다. 이러한 요인들이 복합적으로 작용하여 조직진단에 대한 수요가 꾸준히 증가하면서 시장을 견인하고 있습니다.

부문

제품(소모품, 기기), 기술(면역조직화학, In Situ Hybridization, 특수 염색, 디지털 병리학＆워크플로우), 최종사용자(병원, 제약회사, 연구 실험실, 기타 최종사용자)

조사 대상 기업 예(총 61개사)

  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio SB Inc.
  • Bio-Genex Laboratories
  • Cell Signaling Technology, Inc.
  • F. Hoffmann-La Roche Ltd
  • Leica Biosystems Nussloch GmbH
  • Merck KGaA
  • QIAGEN N.V.
  • Sakura Finetek Japan Co., Ltd.
  • Thermo Fisher Scientific Inc.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.07.08

Global Tissue Diagnostics Market to Reach US$9.5 Billion by 2030

The global market for Tissue Diagnostics estimated at US$6.5 Billion in the year 2024, is expected to reach US$9.5 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.4 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 9.2% CAGR

The Tissue Diagnostics market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Tissue Diagnostics Market - Key Trends & Drivers Summarized

What Are Tissue Diagnostics and Their Importance?

Tissue diagnostics involves the analysis of tissue samples to diagnose diseases, particularly cancer. This field includes techniques such as histopathology, immunohistochemistry, in situ hybridization, and digital pathology. Tissue diagnostics is crucial for accurate disease diagnosis, prognosis, and treatment planning. It allows for the examination of cellular structures, the identification of abnormal cells, and the detection of specific biomarkers associated with various diseases. The precision and reliability of tissue diagnostics are vital for guiding clinical decisions and improving patient outcomes.

How Are Technological Advancements Shaping This Market?

Technological advancements are significantly shaping the tissue diagnostics market. The development of digital pathology, which involves the digitization of tissue samples for analysis and storage, is revolutionizing the field. Digital pathology enables remote consultations, enhances diagnostic accuracy, and facilitates the sharing of data for research and education. Advances in imaging technologies, such as high-resolution scanners and AI-powered image analysis, are improving the detection and characterization of tissue abnormalities. Additionally, the integration of molecular diagnostics with tissue analysis is providing deeper insights into the genetic and molecular underpinnings of diseases, leading to more personalized and targeted therapies.

What Role Do Market Demands Play in This Industry?

Market demands are driving significant changes in the tissue diagnostics market. The rising prevalence of cancer and other chronic diseases is increasing the need for accurate and timely diagnostics, boosting demand for advanced tissue diagnostic tools. The shift towards personalized medicine, which requires detailed molecular and genetic analysis, is influencing the development and adoption of innovative tissue diagnostics technologies. The expanding geriatric population, with its higher incidence of various diseases, further fuels the need for sophisticated diagnostic instruments. Moreover, the increasing focus on early disease detection and preventive healthcare is prompting laboratories and healthcare facilities to invest in cutting-edge tissue diagnostics solutions.

What Factors Are Driving Market Growth?

The growth in the tissue diagnostics market is driven by several factors, including the rising incidence of cancer and other chronic diseases, advancements in diagnostic technologies, and increasing healthcare expenditure. The demand for precise and early diagnostic tools is propelling market growth, as early detection can significantly improve treatment outcomes. Technological innovations, such as digital pathology and AI-driven diagnostic tools, are enhancing the efficiency and accuracy of disease diagnosis. Additionally, the growing trend towards personalized medicine is driving the need for advanced tissue diagnostics that can provide detailed molecular and genetic insights. The expansion of healthcare infrastructure in emerging markets, along with government initiatives to improve diagnostic capabilities, is also contributing to the market's growth. These factors collectively ensure a robust demand for tissue diagnostics, driving the market forward.

SCOPE OF STUDY:

The report analyzes the Tissue Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables, Instruments); Technology (Immunohistochemistry, In Situ Hybridization, Special Staining, Digital Pathology & Workflow); End-Use (Hospitals, Pharma Companies, Research Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 61 Featured) -

  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio SB Inc.
  • Bio-Genex Laboratories
  • Cell Signaling Technology, Inc.
  • F. Hoffmann-La Roche Ltd
  • Leica Biosystems Nussloch GmbH
  • Merck KGaA
  • QIAGEN N.V.
  • Sakura Finetek Japan Co., Ltd.
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Tariff Impact on Global Supply Chain Patterns
    • Tissue Diagnostics: A Prelude
    • Global Economic Update
    • Global Market Outlook
    • Immunohistochemistry Emerges as the Major Tissue Diagnostic Test
    • Breast Cancer Leads the Application Market for Tissue Diagnostics
    • Hospitals Represent the Leading End-Use Segment
    • Developed Regions Lead, Developing Economies to Spearhead Growth
    • Competition
    • Tissue Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Cancer Incidence Worldwide Spurs Demand for Tissue Diagnostics
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Expanding Role of Tissue Diagnostics in Oncology
    • Aging Population and Changing Lifestyles Drive Cancer Incidence, Fueling Prospects for Tissue Diagnostics Market
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Increasing Healthcare Spending Augurs Well for the Market
    • Growing Significance of Personalized Medicine: An Opportunity for Tissue Diagnostics Market
    • Global Personalized Medicines Market in US$ Billion for the Years 2022, 2024, 2026 and 2028
    • Liquid Biopsies Grow in Value as a Diagnostic Tool Supporting Therapy Decisions in NSCLCs
    • Sustained Advancements in Tissue Diagnostics Space Fuel Market Prospects
    • Market to Benefit from Digitalization of Tissue Diagnostic Techniques & Automated Tissue Diagnostic Systems
    • Increase in Companion Diagnostics for Targeted Therapies
    • Companion Diagnostics Accelerate Role of Personalized Medicine in Cancer Care
    • Demand Continues to Surge for Digital Pathology
    • Digital Pathology Emerges as a Tool to Reduce Cases of Cancer Misdiagnoses
    • Future Developments in Digital Pathology to Influence Market Growth
    • AI Steps in to Widen the Scope & Span of Digital Pathology
    • Growing Importance of AI in Digital Pathology
    • CROs and Biopharma Companies Leverage Digital Pathology for Drug Discovery
    • Anatomic Pathology: Poised for Growth
    • Computational Pathology Holds the Potential to Transform Cancer Diagnostics
    • Constantly Increasing Number of Patients Suffering from Chronic Ailments Fuel Demand for Immunohistochemistry
    • Automated Tissue Dissection: Potential to Improve Precision of Molecular Tests
    • Tissue Diagnostics Market in India: An Overview
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Tissue Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Tissue Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for in Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for in Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for in Situ Hybridization by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Special Staining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Special Staining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Special Staining by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Digital Pathology & Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Digital Pathology & Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Digital Pathology & Workflow by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Pharma Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Research Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Tissue Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Tissue Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Tissue Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Tissue Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제